{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:50:51Z","timestamp":1777366251504,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,23]]},"DOI":"10.7759\/cureus.31831","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T18:27:11Z","timestamp":1669228031000},"source":"Crossref","is-referenced-by-count":4,"title":["Rapid and Sustained Effect of Ozone Major Autohemotherapy for Raynaud and Hand Edema in Systemic Sclerosis Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Felice","family":"Galluccio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"1016","author":"Denton CP","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet . 390, 1016:0140-6736. 10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"ref2","article-title":"Vascular involvement in systemic sclerosis","volume":"22","author":"Kahaleh BM","year":"2004","unstructured":"Kahaleh BM. Vascular involvement in systemic sclerosis. Clin Exp Rheumatol. 2004, 22:19-23.","journal-title":"Clin Exp Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.11310","article-title":"Raynaud's phenomenon and the role of capillaroscopy","volume":"48","author":"Cutolo M","year":"2003","unstructured":"Cutolo M, Grassi W, Cerinic MM. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum. 2003, 48:3023-30. 10.1002\/art.11310","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud's phenomenon-an update on diagnosis, classification and management","volume":"38","author":"Pauling JD","year":"2019","unstructured":"Pauling JD, Hughes M, Pope JE. Raynaud's phenomenon-an update on diagnosis, classification and management. Clin Rheumatol. 2019, 38:3317-30. 10.1007\/s10067-019-04745-5","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.008","article-title":"Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis","volume":"10","author":"Galluccio F","year":"2011","unstructured":"Galluccio F, Matucci-Cerinic M. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis. Autoimmun Rev. 2011, 10:241-3. 10.1016\/j.autrev.2010.09.008","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/med.20150","article-title":"The ozone paradox: ozone is a strong oxidant as well as a medical drug","volume":"29","author":"Bocci V","year":"2009","unstructured":"Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009, 29:646-82. 10.1002\/med.20150","journal-title":"Med Res Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/11539890-000000000-00000","article-title":"Ozone: a new therapeutic agent in vascular diseases","volume":"11","author":"Bocci V","year":"2011","unstructured":"Bocci V, Zanardi I, Travagli V. Ozone: a new therapeutic agent in vascular diseases. Am J Cardiovasc Drugs. 2011, 11:73-82. 10.2165\/11539890-000000000-00000","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2001.0867","article-title":"Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats","volume":"44","author":"Al-Dalain SM","year":"2001","unstructured":"Al-Dalain SM, Mart\u00ednez G, Candelario-Jalil E, Men\u00e9ndez S, Re L, Giuliani A, Le\u00f3n OS. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res. 2001, 44:391-6. 10.1006\/phrs.2001.0867","journal-title":"Pharmacol Res"},{"key":"ref9","article-title":"Non-invasive oxygen-ozone therapy in treating digital ulcers of patients with systemic sclerosis","volume":"43","author":"Hassanien M","year":"2018","unstructured":"Hassanien M, Rashad S, Mohamed N, Elawamy A, Ghaly MS. Non-invasive oxygen-ozone therapy in treating digital ulcers of patients with systemic sclerosis. Acta Reumatol Port. 2018, 43:210-6.","journal-title":"Acta Reumatol Port"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roab117","article-title":"Efficacy of local oxygen-ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: a randomized controlled study","volume":"32","author":"Kaymaz S","year":"2022","unstructured":"Kaymaz S, Karasu U, Alkan H, et al.. Efficacy of local oxygen-ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: a randomized controlled study. Mod Rheumatol. 2022, 32:1102-7. 10.1093\/mr\/roab117","journal-title":"Mod Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka O","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, et al.. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017, 76:1327-39. 10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"},{"key":"ref12","unstructured":"The International Scientific Committee of Ozone Therapy. major autohemotherapy. (2022). Accessed: November 10, 2022: https:\/\/isco3.org\/wp-content\/uploads\/2017\/03\/ISCO3-MET-00-01-MAHT-V1-03102016.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.840623","article-title":"Updated review on ozone therapy in pain medicine","volume":"13","author":"Hidalgo-Tall\u00f3n FJ","year":"2022","unstructured":"Hidalgo-Tall\u00f3n FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD, Pinto-Bonilla R. Updated review on ozone therapy in pain medicine. Front Physiol. 2022, 13:840623. 10.3389\/fphys.2022.840623","journal-title":"Front Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex200","article-title":"Points to consider for skin ulcers in systemic sclerosis","volume":"56","author":"Galluccio F","year":"2017","unstructured":"Galluccio F, Allanore Y, Czirjak L, Furst DE, Khanna D, Matucci-Cerinic M. Points to consider for skin ulcers in systemic sclerosis. Rheumatology (Oxford). 2017, 56:v67-71. 10.1093\/rheumatology\/kex200","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/126101-rapid-and-sustained-effect-of-ozone-major-autohemotherapy-for-raynaud-and-hand-edema-in-systemic-sclerosis-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:20Z","timestamp":1707507740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/126101-rapid-and-sustained-effect-of-ozone-major-autohemotherapy-for-raynaud-and-hand-edema-in-systemic-sclerosis-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.31831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}